RecallDepth
Class II Terminated

Mirtazapine Tablets, USP, 45 mg. Rx only, 100 Tablets (10 X 10). Manufactured by: Mylan Pharmaceuticals Inc, Morgantown, WV ---NDC 51079-088-20

Company
Mylan Institutional, Inc. (D.B.A. Udl Laboratories)
Recall Initiated
January 27, 2017
Posted
March 15, 2017
Recall Number
D-0493-2017
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
58 UD100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each)
Firm Location
Rockford, IL, United States

Reason for Recall

Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablets commingled

Distribution

Nationwide

Lot / Code Info

Batch #3083289; Exp. Date 12/2018

More recalls by Mylan Institutional, Inc. (D.B.A. Udl Laboratories)

View all recalls by this company →

Other recent Class II Drug recalls